Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon

Cell Biochemistry and Function

Volumn 30, Issue 4, 2012, Pages 271-278

  Liu, Yawei ^a   Song, Fangli ^a   Wu, William K K ^d   He, Minyi ^b   Zhao, Liang ^a   Sun, Xuegang ^a   Li, Hui ^c   Jiang, Yong ^a   Yang, Yungao ^a   Peng, Kang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c Guangzhou Promoter Biotechnology Limited Corporation   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

14 3 3 epsilon; Colorectal cancer; Proteomics; Triptolide

Indexed keywords

PROTEIN 14 3 3; PROTEIN 14 3 3 EPSILON; TRIPTOLIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEOMICS;

TRIPTERYGIUM WILFORDII;

EID: 84862791482     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2793     Document Type: Article

References (21)

1. Kupchan SM, Court WA, Dailey RG, Jr, Gilmore CJ, Bryan RF. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc 1972; 94: 7194-7195.
2. Qiu D, Zhao G, Aoki Y, et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 1999; 274: 13443-13450.
3. Chen BJ, Liu C, Cui X, Fidler JM, Chao NJ. Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion. Transplantation 2000; 70: 1442-1447.
4. Cibere J, Deng Z, Lin Y, et al. A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis. J Rheumatol 2003; 30: 465-467.
5. Pan J. RNA polymerase - An important molecular target of triptolide in cancer cells. Cancer Lett 2009; 292: 149-152.
6. Yang S, Chen J, Guo Z, et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2003; 2: 65-72.
7. Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 2002; 8: 2666-2674.
8. Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 2009; 19: 16-23.
9. Nielsen MD, Luo X, Biteau B, Syverson K, Jasper H. 14-3-3 Epsilon antagonizes FoxO to control growth, apoptosis and longevity in Drosophila. Aging Cel 2008; 7: 688-699.
10. Milton AH, Khaire N, Ingram L, O'Donnell AJ, La Thangue NB. 14-3-3 proteins integrate E2F activity with the DNA damage response. EMBO J 2006; 25: 1046-1057.
11. Matsui Y, Watanabe J, Ikegawa M, Kamoto T, Ogawa O, Nishiyama H. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. Oncogene 2008; 27: 4603-4614.
12. Oriente F, Andreozzi F, Romano C, et al. Protein kinase C-alpha regulates insulin action and degradation by interacting with insulin receptor substrate-1 and 14-3-3 epsilon. J Biol Chem 2005; 280: 40642-40649.
13. Rajagopalan S, Sade RS, Townsley FM, Fersht AR. Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms. Nucleic Acids Res 2010; 38: 893-906.
14. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003; 3: 931-943.
15. Brunet A, Kanai F, Stehn J, et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol 2002; 156: 817-828.
16. Dalal SN, Yaffe MB, DeCaprio JA. 14-3-3 family members act coordinately to regulate mitotic progression. Cell Cycle 2004; 3: 672-677.
17. Takemaru K, Yamaguchi S, Lee YS, Zhang Y, Carthew RW, Moon RT. Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway. Nature 2003; 422: 905-909.
18. Li FQ, Mofunanya A, Harris K, Takemaru K. Chibby cooperates with 14-3-3 to regulate bcatenin subcellular distribution and signaling activity. J Cell Biol 2008; 181: 1141-1154.
19. Kuzelová K, Grebenová D, Pluskalová M, Kavan D, Halada P, Hrkal Z. Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. J Cell Biochem 2009; 106: 673-681.
20. Liang S, Xu Y, Shen G, et al. Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis 2009; 30: 4152-4162.
21. Won J, Kim DY, La M, Kim D, Meadows GG, Joe CO. Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x (L) during apoptosis. J Biol Chem 2003; 278: 19347-19351.